UCB stock heads into the open after a 0.89 percent drop
Published on 09/24/2026 at 05:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
UCB stock closed at EUR 211.60 on Euronext Brussels on September 23, 2026, down 0.89 percent. The shares underperformed the broader Brussels market as La Libre reported that the BEL 20 moved back below 5,700 points.
September 23, 2026 in numbers
UCB SA (ISIN BE0003739530) traded 297,520 shares on Euronext Brussels. The closing price was EUR 211.60, compared with EUR 213.50 on September 22, 2026, producing the reported daily decline of 0.89 percent.
The stock gained 2.67 percent over the five sessions through September 23, 2026, but remained down 11.32 percent since the start of 2026. Its one-year range was EUR 191.20 to EUR 289.50, placing the latest close EUR 21.40, or 11.2 percent, above the one-year low and EUR 77.90, or 26.9 percent, below the one-year high.
September 24, 2026 events
UCB participated in healthcare investor discussions on September 23, 2026. Investing.com reported comments from the J.P. Morgan European Healthcare CEO Call Series, while a separate conference transcript covered the Bank of America Global Healthcare Conference.
U.S. economic releases scheduled for September 24, 2026 include initial jobless claims, August building permits, the second-quarter current account and August new home sales, according to SVMUU. These data can affect healthcare shares through broader interest-rate and market sentiment channels.
